Tiger BioSciences, through its subsidiary Tiger International RE GmbH, is an investor and strategic partner in Airway Medix, a company focused on developing single-use medical devices for mechanically ventilated patients. The partnership includes a convertible loan and Oliver Burckhardt, a co-CEO of Tiger BioSciences, is slated to join the Airway Medix supervisory board. This collaboration aims to advance Airway Medix's innovative technologies for critical care.